X-energy Adds Dr. Oded Doron to Leadership Team as Vice President of Engineering
ROCKVILLE, Md.–(BUSINESS WIRE)–X-energy Reactor Company, LLC (“X-energy” or the “Company”), a leading developer of advanced small modular nuclear... Read more.
NewSound Unveils Groundbreaking AI-Driven OTC Hearing Aids, Revolutionizing Hearing Accessibility with AI Acceleration by Femtosense
NEW ORLEANS–(BUSINESS WIRE)–#ArtificialIntelligence–NewSound, a leading innovator in hearing aids with over two decades of expertise, today launched... Read more.
Satellos Reports 2024 Financial Results and Highlights Company Progress
– Completed enrollment and dosing in a Phase 1a clinical trial in 72 healthy volunteers to assess safety and pharmacokinetic (PK) properties of SAT-3247 – Presented... Read more.
Media Advisory: Ribbon Cutting to Celebrate Noel Place, a New Affordable Housing Development in Jackson, Mississippi
***10:00 a.m., Thursday, March 27, 144 Noel Street, Jackson, Mississippi 39202*** JACKSON, Miss.–(BUSINESS WIRE)–Representatives from the Federal Home... Read more.
TELUS Digital Research Hub Unveiled at University of São Paulo
Research grant applications now open to undergraduate and postgraduate students to advance AI research and development VANCOUVER, British Columbia–(BUSINESS... Read more.
European Commission (EC) Approves Merck’s CAPVAXIVE® (Pneumococcal 21-valent Conjugate Vaccine) for Prevention of Invasive Pneumococcal Disease and Pneumococcal Pneumonia in Adults
EC decision marks the fourth approval for CAPVAXIVE for pneumococcal vaccination in adults RAHWAY, N.J.–(BUSINESS WIRE)–$MRK #MRK–Merck (NYSE:... Read more.
Agellus Capital Completes Investment in Orcus Fire & Risk as an Addition to its National Fire and Life Safety Acquisition Platform
CLAYTON, Mo.–(BUSINESS WIRE)–Agellus Capital announced today the acquisition of Houston-based Orcus Fire & Risk. Orcus Fire & Risk will be joining... Read more.
BIOQuébec’s Response to the Quebec Government Budget
Quebec Focuses on Innovation and Life Sciences LAVAL, Quebec–(BUSINESS WIRE)–BIOQuébec acknowledges the Quebec government’s recognition of the life... Read more.
Compass Pathways Announces Completion of Recruitment for the Phase 3 COMP005 Trial of COMP360 Psilocybin for Treatment-Resistant Depression
Highlights: Screening closed for all sites and final participants being scheduled for dosing On track for top-line 6-week primary endpoint results in late Q2 LONDON... Read more.
UCTT INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Ultra Clean Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
SAN DIEGO–(BUSINESS WIRE)–The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Ultra Clean Holdings, Inc. (NASDAQ:... Read more.